These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7359372)

  • 1. Phenytoin pharmacokinetics in burned rats and plasma protein binding of phenytoin in burned patients.
    Bowdle TA; Neal GD; Levy RH; Heimbach DM
    J Pharmacol Exp Ther; 1980 Apr; 213(1):97-9. PubMed ID: 7359372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma protein binding and metabolic clearance of phenytoin in the rat.
    Colburn WA; Gibaldi M
    J Pharmacol Exp Ther; 1977 Dec; 203(3):500-6. PubMed ID: 925955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of d-tubocurarine in patients with thermal injury.
    Martyn JA; Matteo RS; Greenblatt DJ; Lebowitz PW; Savarese JJ
    Anesth Analg; 1982 Mar; 61(3):241-6. PubMed ID: 7199837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of salicylate on maternal and fetal phenytoin pharmacokinetics in rats.
    Cleveland PA; Ueda CT
    Drug Metab Dispos; 1984; 12(3):285-90. PubMed ID: 6145554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pregnancy on the pharmacokinetics of phenytoin in rats.
    Chou RC; Levy G
    J Pharmacol Exp Ther; 1984 May; 229(2):351-8. PubMed ID: 6716263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin and valproate in the rat.
    O'Leary TD; Sansom LN
    J Pharmacol Exp Ther; 1981 Mar; 216(3):613-6. PubMed ID: 6782238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged impairment of the plasma-protein binding of phenytoin in the rat after a single dose of sodium oleate.
    Colburn WA; Gibaldi M
    Drug Metab Dispos; 1978; 6(4):452-5. PubMed ID: 28926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in serum protein binding and pharmacokinetics of l-propranolol in the rat elicited by the presence of an indwelling venous catheter.
    Terao N; Shen DD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):369-75. PubMed ID: 6631719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of heparin or salicylate infusion on serum protein binding and on concentrations of phenytoin in serum, brain and cerebrospinal fluid of rats.
    Chou RC; Levy G
    J Pharmacol Exp Ther; 1981 Oct; 219(1):42-8. PubMed ID: 7288614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of age and dose on the pharmacokinetics of ibuprofen in the rat.
    Satterwhite JH; Boudinot FD
    Drug Metab Dispos; 1991; 19(1):61-7. PubMed ID: 1673423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.
    Joerger M; Huitema AD; Boogerd W; van der Sande JJ; Schellens JH; Beijnen JH
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):133-40. PubMed ID: 16918714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenytoin toxicity and blood levels after a large oral dose.
    Evens RP; Fraser DG; Ludden TM; Sutherland EW
    Am J Hosp Pharm; 1980 Feb; 37(2):232-5. PubMed ID: 7361796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of plasma free phenytoin measurement and factors influencing its protein binding.
    Iwamoto T; Kagawa Y; Naito Y; Kuzuhara S; Okuda M
    Biopharm Drug Dispos; 2006 Mar; 27(2):77-84. PubMed ID: 16308884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenytoin disposition in smokers and nonsmokers.
    Rose JQ; Barron SA; Jusko WJ
    Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):547-50. PubMed ID: 730422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting serum protein binding of phenytoin, diazepam and propranolol in acute renal diseases.
    Tiula E; Haapanen EJ; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1987 Sep; 25(9):469-75. PubMed ID: 3679617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single dose phenytoin clearance during erythromycin treatment.
    Bachmann K; Schwartz JI; Forney RB; Jauregui L
    Res Commun Chem Pathol Pharmacol; 1984 Nov; 46(2):207-17. PubMed ID: 6515115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition and induction of drug biotransformation in vivo by 8-methoxypsoralen: studies of caffeine, phenytoin and hexobarbital metabolism in the rat.
    Mays DC; Nawoot S; Hilliard JB; Pacula CM; Gerber N
    J Pharmacol Exp Ther; 1987 Oct; 243(1):227-33. PubMed ID: 3668854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of blood sampling schedules on protein drug binding in the rat.
    Hulse M; Feldman S; Bruckner JV
    J Pharmacol Exp Ther; 1981 Aug; 218(2):416-20. PubMed ID: 6166741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma protein binding of phenytoin in health and disease: relevance to therapeutic drug monitoring.
    Perucca E
    Ther Drug Monit; 1980; 2(4):331-44. PubMed ID: 7013166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.